Bioperfectus Emergency Response Training for Ebola Virus Diagnostics and Testing

Company news

Today, Bioperfectus conducted emergency training to assist frontline healthcare professionals in Uganda using Real-Time PCR diagnostic tools for early detection and control of the latest Ebola outbreak. Technical staff from Central Public Health Laboratories of the Uganda Ministry of Health and the customer service team of Bioperfectus attended this workshop.



This training workshop focused on the instruction and operating procedure of Bioperfectus Ebola Virus Real Time PCR Kits, which ensures laboratory test results are accurate, reliable, and timely. 



Bioperfectus was the first Chinese company to provide Ebola Virus Real Time PCR Kits to combat the recent Ebola outbreak in African regions, collaborating with Africa Centres for Disease Control and Prevention (Africa CDC), African Union, and the African Society for Laboratory Medicine (ASLM).


As one of the leading global molecular diagnostics suppliers, Bioperfectus is dedicated to protecting the public's health and safety by delivering timely responses, excellent services, and products that meet the highest global quality and safety standards.





Bioperfectus and World Health Organization (WHO) Collaborate on Molecular Diagnostics

A batch of Bioperfectus-developed Nucleic Acid Extraction System SSNP-2000B began shipping today to World Health Organization (WHO). The distribution of Bioperfectus SSNP-2000B Nucleic Acid Extraction System will support the development of molecular diagnostics in Africa.


Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.


Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.